For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Scope of the Report:
This report focuses on the Closed System Drug Transfer Device (CSTD) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
USA dominated the Closed System Drug Transfer Device (CSTD), and is the largest production base. In addition to USA, there are some other production areas, such as Europe. In consumption market, North America is the mainly consumption regions due to the bigger demand of downstream applications. In 2017, North America occupied 89.37% of the global consumption value in total. But the above forecast is based on the current policy. If a country suddenly made the relevant policies, then the entire market will change.
The worldwide market for Closed System Drug Transfer Device (CSTD) is expected to grow at a CAGR of roughly 22.9% over the next five years, will reach 1580 million US$ in 2023, from 460 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- BD Medical, Inc
- Equashield, LLC
- ICU Medical, Inc
- Teva Medical Ltd
- Corvida Medical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Closed Vial Access Devices
- Closed Syringe Safety Devices
- Closed Bag/Line Access Devices
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Closed System Drug Transfer Device (CSTD) market.
Chapter 1, to describe Closed System Drug Transfer Device (CSTD) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Closed System Drug Transfer Device (CSTD), with sales, revenue, and price of Closed System Drug Transfer Device (CSTD), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Closed System Drug Transfer Device (CSTD), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Closed System Drug Transfer Device (CSTD) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Closed System Drug Transfer Device (CSTD) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source